A phase 1 study to address the safety an
โ
Dennis McGonagle; Andrew Rawstron; Stephen Richards; John Isaacs; Howard Bird; A
๐
Article
๐
1997
๐
John Wiley and Sons
๐
English
โ 488 KB
๐ 2 views
## Objective: To examine the safety and efficacy of granulocyte colony-stimulating factor (g-csf) alone for the mobilization of peripheral blood progenitor cells in patients with resistant active rheumatoid arthritis (ra). ## Methods: Five patients with resistant active ra were studied. a dose of